The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release
Open accessAbstract
Photothermal ablation (PTA) is an emerging technique that uses near-infrared (NIR) laser light-generated heat to destroy tumor cells. However, complete eradication of tumor cells with PTA is difficult because of uneven heat distribution in the treatment volume. We hypothesized that combining PTA with chemotherapy using a single multifunctional nanoconstruct that mediates simultaneous photothermal cell killing and drug release (photothermal-chemotherapy) would result in enhanced antitumor activity and reduced toxicity compared to chemotherapy alone. Doxorubicin (DOX) was loaded to hollow gold nanospheres (HAuNS) coated with polyethylene glycol (PEG). The pharmacokinetics and biodistribution of both DOX and HAuNS in the resulting nanoconstruct, DOX@PEG-HAuNS having different DOX:PEG:HAuNS ratios, were evaluated using dual isotope labeling techniques. The antitumor activity of DOX@PEG-HAuNS with DOX:PEG:HAuNS weight ratio of 1:3:1 (NP3) in combination with NIR laser was studied in vitro and in vivo using human MDA-MB-231 breast cancer and A2780 ovarian cancer cells. In vitro, NP3 mediated PTA of both cancer cells and DOX release upon NIR laser treatment. In vivo, NP3 showed slower clearance in blood and greater accumulation in tumors than free DOX. NP3-plus-NIR laser demonstrated greater antitumor activity than free DOX, NP3, or liposomal DOX. Moreover, NP3 displayed significantly decreased systemic toxicity compared to free DOX or liposomal DOX. Enhanced antitumor effect with NP3-plus-laser can be attributed to both the cytotoxic effect of DOX released from NP3 and the photothermal effect mediated by HAuNS. Slow release of DOX from NP3 in normal tissues contributed to reduced systemic toxicity. Photothermal-chemotherapy exemplified by a single-agent nanoconstruct NP3 is a promising approach to anticancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
Cited by
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,425
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Gold Nanomaterials at Work in Biomedicine
Yang, X., Yang, M., Pang, B., Vara, M., & Xia, Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00193 · Cited by 1,162
Anisotropic Gold Nanoparticles: Synthesis, Properties, Applications, and Toxicity
Li, N., Zhao, P., & Astruc, D. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201300441 · Cited by 962
Near-infrared light-responsive nanomaterials in cancer therapeutics
Shanmugam, V., Selvakumar, S., & Yeh, C.-S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00011k · Cited by 869
Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease
Mieszawska, A. J., Mulder, W. J. M., Fayad, Z. A., & Cormode, D. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005885 · Cited by 724
Near‐Infrared Light‐Mediated Nanoplatforms for Cancer Thermo‐Chemotherapy and Optical Imaging
Zhang, Z., Wang, J., & Chen, C. (2013) · Advanced Materials · doi:10.1002/adma.201301890 · Cited by 634
Controlled drug release from pharmaceutical nanocarriers
Lee, J. H., & Yeo, Y. (2015) · Chemical Engineering Science · doi:10.1016/j.ces.2014.08.046 · Cited by 628
Injectable hydrogel-based drug delivery systems for local cancer therapy
Norouzi, M., Nazari, B., & Miller, D. W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.006 · Cited by 558
Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 506
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2017) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436
Wang, X., Zhang, J., Wang, Y., Wang, C., Xiao, J., Zhang, Q., & Cheng, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.037 · Cited by 411
Carbon nanotubes: a novel material for multifaceted applications in human healthcare
Kumar, S., Rani, R., Dilbaghi, N., Tankeshwar, K., & Kim, K.-H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00517a · Cited by 397
Chen, M.-C., Lin, Z.-W., & Ling, M.-H. (2016) · ACS Nano · doi:10.1021/acsnano.5b05043 · Cited by 358
Dong, K., Liu, Z., Li, Z., Ren, J., & Qu, X. (2013) · Advanced Materials · doi:10.1002/adma.201301232 · Cited by 325
Zhu, X., Li, J., Qiu, X., Liu, Y., Feng, W., & Li, F. (2018) · Nature Communications · doi:10.1038/s41467-018-04571-4 · Cited by 276
Self-citationGold nanoparticles in breast cancer treatment: Promise and potential pitfalls
Lee, J., Chatterjee, D. K., Lee, M. H., & Krishnan, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.006 · Cited by 271
A targeted approach to cancer imaging and therapy
Li, C. (2014) · Nature Materials · doi:10.1038/nmat3877 · Cited by 268
Self-citationDistribution of gold nanoparticles into the brain: a systematic review and meta-analysis
Behroozi, Z., Rahimi, B., Kookli, K., Safari, M. S., Hamblin, M. R., Razmgir, M., Janzadeh, A., & Ramezani, F. (2021) · Nanotoxicology · doi:10.1080/17435390.2021.1966116 · Cited by 19
Metadata
- Authors
- You, J., Zhang, R., Zhang, G., Zhong, M., Liu, Y., Van Pelt, C. S., Liang, D., Wei, W., Sood, A. K., & Li, C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 158
- Issue
- 2
- Pages
- 319-328
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1967788087
- Cited by
- 211
- References
- 1
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.